8
Participants
Start Date
September 10, 2020
Primary Completion Date
November 17, 2020
Study Completion Date
November 17, 2020
20 mg/120 mg artemether-lumefantrine (AL) + 20 mg ruxolitinib phosphate (Rux)
Rux administered 2 hours after AL administration, twice daily (b.i.d) for 3 consecutive days (6 doses in total).
20 mg/120 mg artemether-lumefantrine (AL) + Placebo
Placebo administered 2 hours after AL administration, twice daily (b.i.d) for 3 consecutive days (6 doses in total).
Nucleus Network Brisbane, Brisbane
Collaborators (2)
Southern Star Research
INDUSTRY
Nucleus Network Ltd
OTHER
Medicines for Malaria Venture
OTHER